AZD7762
D1040C00008
Phase 1 small_molecule terminated
Quick answer
AZD7762 for Cancer is a Phase 1 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated